Triglyceride-Glucose Index is a Risk Marker of Incident COPD Events in Women

References

• Cebron Lipovec N, Beijers RJH, van den Borst B, Doehner W, Lainscak M, Schols AM. The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: a systematic review. COPD. 2016;13(3):399–406. doi:10.3109/15412555.2016.1140732
   PubMedGoogle Scholar
• Jones PW, Nadeau G, Small M, Adamek L. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med. 2014;108(1):129–135. doi:10.1016/j.rmed.2013.08.015
   PubMed Web of Science ®Google Scholar
• Park SK, Larson JL. The relationship between physical activity and metabolic syndrome in people with chronic obstructive pulmonary disease. J Cardiovasc Nurs. 2014;29(6):499–507. doi:10.1097/JCN.0000000000000096
   PubMed Web of Science ®Google Scholar
• Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2003;52(7):1799–1805. doi:10.2337/diabetes.52.7.1799
   PubMed Web of Science ®Google Scholar
• Muhammad IF, Borné Y, Hedblad B, Nilsson PM, Persson M, Engström G. Acute-phase proteins and incidence of diabetes: a population-based cohort study. Acta Diabetol. 2016;53(6):981–989. doi:10.1007/s00592-016-0903-8
   PubMed Web of Science ®Google Scholar
• Miller J, Edwards LD, Agustí A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107(9):1376–1384. doi:10.1016/j.rmed.2013.05.001
   PubMed Web of Science ®Google Scholar
• Parappil A, Depczynski B, Collett P, Marks GB. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology. 2010;15(6):918–922. doi:10.1111/j.1440-1843.2010.01781.x
   PubMed Web of Science ®Google Scholar
• Glaser S, Kruger S, Merkel M, Bramlage P, Herth FJ. Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature. Respir Int Rev Thoracic Dis. 2015;89(3):253–264. doi:10.1159/000369863
   Web of Science ®Google Scholar
• Ehrlich SF, Quesenberry CP, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care. 2010;33(1):55–60. doi:10.2337/dc09-0880
   PubMed Web of Science ®Google Scholar
• Lim SY, Rhee E-J, Sung K-C. Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males. J Korean Med Sci. 2010;25(10):1480–1486. doi:10.3346/jkms.2010.25.10.1480
   PubMed Web of Science ®Google Scholar
• Sagun G, Gedik C, Ekiz E, Karagoz E, Takir M, Oguz A. The relation between insulin resistance and lung function: a cross sectional study. BMC Pulm Med. 2015;15(1):139. doi:10.1186/s12890-015-0125-9
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. doi:10.1089/met.2008.0034
   PubMedGoogle Scholar
• Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivityComparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351. doi:10.1210/jc.2010-0288
   PubMed Web of Science ®Google Scholar
• Vasques ACJ, Novaes FS, de Oliveira M, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100. doi:10.1016/j.diabres.2011.05.030
   PubMed Web of Science ®Google Scholar
• Lawlor DA, Ebrahim S, Davey Smith G. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health Study. Diabetologia. 2004;47(2):195–203. doi:10.1007/s00125-003-1310-6
   PubMed Web of Science ®Google Scholar
• Wu TD, Fawzy A, Brigham E, et al. Association of triglyceride-glucose index and lung health: a population-based study. Chest. 2021;160(3):1026–1034. doi:10.1016/j.chest.2021.03.056
   PubMed Web of Science ®Google Scholar
• Berglund G, Nilsson P, Eriksson KF, et al. Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med. 2000;247(1):19–29. doi:10.1046/j.1365-2796.2000.00568.x
   PubMed Web of Science ®Google Scholar
• Nilsson P, Nilsson JA, Hedblad B, Eriksson KF, Berglund G. Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: the Malmö Preventive Project. J Intern Med. 2003;253(2):136–145. doi:10.1046/j.1365-2796.2003.01064.x
   PubMed Web of Science ®Google Scholar
• Zaigham S, Nilsson PM, Wollmer P, Engstrom G. The temporal relationship between poor lung function and the risk of diabetes. BMC Pulm Med. 2016;16(1):75. doi:10.1186/s12890-016-0227-z
   PubMed Web of Science ®Google Scholar
• Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253(5):574–581. doi:10.1046/j.1365-2796.2003.01138.x
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Villalobos-Molina R, Jiménez-Flores JR, et al. Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults. Arch Med Res. 2016;47(5):382–387. doi:10.1016/j.arcmed.2016.08.012
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Gamboa-Gómez CI, Aradillas-García C, Rodríguez-Morán M, Guerrero-Romero F. The triglyceride and glucose index is a useful biomarker to recognize glucose disorders in apparently healthy children and adolescents. Eur J Pediatr. 2020;179(6):953–958. doi:10.1007/s00431-020-03570-2
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Guerrero-Romero F. The correct formula for the triglycerides and glucose index. Eur J Pediatr. 2020;179(7):1171. doi:10.1007/s00431-020-03644-1
   PubMed Web of Science ®Google Scholar
• Engström G, Segelstorm N, Ekberg-Aronsson M, Nilsson PM, Lindgärde F, Löfdahl C-G. Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study. Thorax. 2009;64(3):211–215. doi:10.1136/thx.2008.102079
   PubMed Web of Science ®Google Scholar
• Inghammar M, Engstrom G, Lofdahl CG, Egesten A. Validation of a COPD diagnosis from the Swedish inpatient registry. Scand J Public Health. 2012;40(8):773–776. doi:10.1177/1403494812463172
   PubMed Web of Science ®Google Scholar
• Zuberi FF, Bader N, Rasheed T, Zuberi BF. Association between insulin resistance and BMI with FEV1 in non-hypoxemic COPD out-patients. Clin Respir J. 2021;15(5):513–521. doi:10.1111/crj.13336
   PubMed Web of Science ®Google Scholar
• Baffi CW, Wood L, Winnica D, et al. Metabolic Syndrome and the Lung. Chest. 2016;149(6):1525–1534. doi:10.1016/j.chest.2015.12.034
   PubMed Web of Science ®Google Scholar
• Singh S, Prakash YS, Linneberg A, Agrawal A. Insulin and the lung: connecting asthma and metabolic syndrome. J Allergy. 2013;2013:627384. doi:10.1155/2013/627384
   PubMedGoogle Scholar
• Wu L, Ma L, Nicholson LFB, Black PN. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir Med. 2011;105(3):329–336. doi:10.1016/j.rmed.2010.11.001
   PubMed Web of Science ®Google Scholar
• Wijnant SRA, De Roos E, Kavousi M, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J. 2020;55(1):1901217. doi:10.1183/13993003.01217-2019
   PubMed Web of Science ®Google Scholar
• McIvor ER, Saraiva I, Denning J, McIvor RA. Women with COPD. Breathe. 2020;16(4):200239. doi:10.1183/20734735.0239-2020
   Web of Science ®Google Scholar
• Barnes PJ. Sex differences in chronic obstructive pulmonary disease mechanisms. Am J Respir Crit Care Med. 2016;193(8):813–814. doi:10.1164/rccm.201512-2379ED
   PubMed Web of Science ®Google Scholar
• Assad NA, Balmes J, Mehta S, Cheema U, Sood A. Chronic obstructive pulmonary disease secondary to household air pollution. Semin Respir Crit Care Med. 2015;36(3):408–421. doi:10.1055/s-0035-1554846
   PubMed Web of Science ®Google Scholar
• Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 2004;27(12):2898–2904. doi:10.2337/diacare.27.12.2898
   PubMed Web of Science ®Google Scholar
• Tian X, Zuo Y, Chen S, et al. Triglyceride–glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2021;20(1):19. doi:10.1186/s12933-020-01210-5
   PubMed Web of Science ®Google Scholar
• Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404–2411. doi:10.1210/jc.2003-030242
   PubMed Web of Science ®Google Scholar
• Campbell B, Davis SR, Abramson MJ, et al. Menopause, lung function and obstructive lung disease outcomes: a systematic review. Climacteric. 2018;21(1):3–12. doi:10.1080/13697137.2017.1392504
   PubMed Web of Science ®Google Scholar
• Midlov P, Calling S, Sundquist J, Sundquist K, Johansson SE. The longitudinal age and birth cohort trends of smoking in Sweden: a 24-year follow-up study. Int J Public Health. 2014;59(2):243–250. doi:10.1007/s00038-013-0535-5
   PubMed Web of Science ®Google Scholar